We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to tax a beneficial loan arrangement for a director or employee.
How to change, revoke or transfer your licence, including if the licence holder dies or becomes bankrupt and find out when changes can be enforced.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
This contains important actions and clarifications for institutions delivering 16 to 19 provision.
How investigators and sponsors should manage clinical trials during COVID-19
This notice explains how the rules are applied to this quota and how to apply for a licence. It also advises you of the quantity available for the period 1 November 2023 to 31 May 2024. Details of the quantity...
Submission of notifications for northern Ireland under article 20 of directive 2014/40/EU.
This tax information and impact note allows qualifying investors an exemption from Corporation Tax on qualifying disposals of substantial shareholdings.
The CMA investigated the anticipated acquisition by Theramex HQ UK Limited of the European Rights to Viatris’ Femoston and Duphaston Products.
This privacy notice explains your rights and gives information you are entitled to under UK data protection legislation.
An overview of 16 to 19 education funding and how it is calculated.
The CMA investigated the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical.
Substantially equivalent accommodation standards agreed by UK tripartite working group for new vessels of 200GT to less than 500GT.
A foreword on the Department for Levelling Up, Housing and Communities’ commitment to the evaluation of local growth programmes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).